Your browser doesn't support javascript.
loading
The clinical management of lenalidomide-based therapy in patients with newly diagnosed multiple myeloma.
Merz, Maximilian; Dechow, Tobias; Scheytt, Mithun; Schmidt, Christian; Hackanson, Bjoern; Knop, Stefan.
Affiliation
  • Merz M; Department of Internal Medicine V, Multiple Myeloma Division, Heidelberg University Medical Center, Heidelberg, Germany.
  • Dechow T; Private Oncology Practice Ravensburg, Ravensburg, Germany.
  • Scheytt M; Department of Internal Medicine II, Hematology and Medical Oncology Division, Würzburg University Medical Center, Würzburg, Germany.
  • Schmidt C; Grosshadern University Hospital, Department of Internal Medicine III, University Hospital of Ludwig Maximilians University, Munich, Germany.
  • Hackanson B; Department of Internal Medicine II and ICCA, Augsburg University Hospital, Augsburg, Germany.
  • Knop S; Department of Internal Medicine II, Hematology and Medical Oncology Division, Würzburg University Medical Center, Würzburg, Germany. knop_s@ukw.de.
Ann Hematol ; 99(8): 1709-1725, 2020 Aug.
Article in En | MEDLINE | ID: mdl-32296915

Full text: 1 Database: MEDLINE Main subject: Stem Cell Transplantation / Lenalidomide / Multiple Myeloma Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2020 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: Stem Cell Transplantation / Lenalidomide / Multiple Myeloma Type of study: Diagnostic_studies / Guideline Limits: Humans Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2020 Type: Article Affiliation country: Germany